Trial NCT04491994
Publication Kamran S M, Cureus, 2021
Primary outcome on the report: Disease progression within five days of start of treatment. Progression of disease was defined by the development of fever >101 F for >72 hours, shortness of breath with minimal exertion, derangement of basic laboratory parameters (ALC < 1000 or raised CRP), or appearance of infiltrates on X-ray chest

Note: The risk of bias by domain corresponds to the highest risk of bias among outcomes by domain.
The overall risk of bias corresponds to the overall highest risk of bias assessed among outcomes.